Document is current
Any future updates will be listed below
-
Authors
Nagasaka, Mai
Facchinetti, Francesco
Bigot, Ludovic
Brayé, Floriane
Groves, Matthew R.
Yosa, Juvenal
Wekken, Anthonie van der
Aldea, Mihaela
Besse, Benjamin
Planchard, David
Naltet, Charles
Katayama, Ryohei
Olaussen, Ken André
Loriot, Yohann
Friboulet, Luc
-
Funding
Funding for this research was provided by:
MEXT/JSPS KAKENHI (25K18946)
the Embassy of France in Japan and Kiyoko Goto and Paul Bourdarie Cancer Foundation
ERC Consolidator Gran (101044047)
Agence Nationale de la Recherche (ANR-23-IAHU-0002)
- License Information
-
More Information
Article History
Received: 13 February 2026
Accepted: 30 April 2026
First Online: 13 May 2026
Competing interests
: The Authors declare no Competing Non-Financial Interests but the following Competing Financial Interests: F.F. reports speaker fees from Roche. R.K. is an Associate Editor for npj Precision Oncology and was not involved in the journal’s review of, or decisions related to, this manuscript. R.K. reports research funding from Chugai, Nippon Kayaku, TOPPAN, UBE, BML, and Eiken Chemical outside the submitted work, and reports speaker fee from Pfizer, Chugai, TAKEDA, Nippon Kayaku. L.F. reports research funding from Amgen, Sanofi and Nuvalent outside the submitted work.
